492 related articles for article (PubMed ID: 24929038)
21. Rosin: a naturally derived excipient in drug delivery systems.
Kumar S; Gupta SK
Polim Med; 2013; 43(1):45-8. PubMed ID: 23808195
[TBL] [Abstract][Full Text] [Related]
22. Towards a rational basis for selection of excipients: Excipient Efficiency for controlled release.
Casas M; Aguilar-de-Leyva Á; Caraballo I
Int J Pharm; 2015 Oct; 494(1):288-95. PubMed ID: 26253376
[TBL] [Abstract][Full Text] [Related]
23. Natural polymers, gums and mucilages as excipients in drug delivery.
Kumar S; Gupta SK
Polim Med; 2012; 42(3-4):191-7. PubMed ID: 23457960
[TBL] [Abstract][Full Text] [Related]
24. Extended-release oral drug delivery technologies: monolithic matrix systems.
Tiwari SB; Rajabi-Siahboomi AR
Methods Mol Biol; 2008; 437():217-43. PubMed ID: 18369971
[TBL] [Abstract][Full Text] [Related]
25. Solutions as solutions--synthesis and use of a liquid polyester excipient to dissolve lipophilic drugs and formulate sustained-release parenterals.
Asmus LR; Gurny R; Möller M
Eur J Pharm Biopharm; 2011 Nov; 79(3):584-91. PubMed ID: 21820511
[TBL] [Abstract][Full Text] [Related]
26. Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs.
Porter CJ; Trevaskis NL; Charman WN
Nat Rev Drug Discov; 2007 Mar; 6(3):231-48. PubMed ID: 17330072
[TBL] [Abstract][Full Text] [Related]
27. Formulation strategy and use of excipients in pulmonary drug delivery.
Pilcer G; Amighi K
Int J Pharm; 2010 Jun; 392(1-2):1-19. PubMed ID: 20223286
[TBL] [Abstract][Full Text] [Related]
28. Spray congealing: a versatile technology for advanced drug-delivery systems.
Bertoni S; Dolci LS; Albertini B; Passerini N
Ther Deliv; 2018 Nov; 9(11):833-845. PubMed ID: 30444462
[TBL] [Abstract][Full Text] [Related]
29. Advances in lipid nanodispersions for parenteral drug delivery and targeting.
Constantinides PP; Chaubal MV; Shorr R
Adv Drug Deliv Rev; 2008 Mar; 60(6):757-67. PubMed ID: 18096269
[TBL] [Abstract][Full Text] [Related]
30. Excipient variability and its impact on dosage form functionality.
Dave VS; Saoji SD; Raut NA; Haware RV
J Pharm Sci; 2015 Mar; 104(3):906-15. PubMed ID: 25561249
[TBL] [Abstract][Full Text] [Related]
31. [Technological and pharmacotherapeutic properties of selected drugs with modified release of diclofenac sodium].
Kołodziejczyk MK; Kołodziejska J; Zgoda MM
Polim Med; 2012; 42(2):121-32. PubMed ID: 23016443
[TBL] [Abstract][Full Text] [Related]
32. Delayed release film coating applications on oral solid dosage forms of proton pump inhibitors: case studies.
Missaghi S; Young C; Fegely K; Rajabi-Siahboomi AR
Drug Dev Ind Pharm; 2010 Feb; 36(2):180-9. PubMed ID: 20070183
[TBL] [Abstract][Full Text] [Related]
33. Recent trends in stabilising peptides and proteins in pharmaceutical formulation - considerations in the choice of excipients.
Jorgensen L; Hostrup S; Moeller EH; Grohganz H
Expert Opin Drug Deliv; 2009 Nov; 6(11):1219-30. PubMed ID: 19678792
[TBL] [Abstract][Full Text] [Related]
34. Formulation and evaluation of Ficus glomerata mucilage sustained release matrix tablets of gliclazide.
Kumar CS; Reddy-Budideti KK; Battula SP; Ayyavala CS
Pak J Pharm Sci; 2011 Jul; 24(3):399. PubMed ID: 21715275
[TBL] [Abstract][Full Text] [Related]
35. Role of excipients in successful development of self-emulsifying/microemulsifying drug delivery system (SEDDS/SMEDDS).
Rahman MA; Hussain A; Hussain MS; Mirza MA; Iqbal Z
Drug Dev Ind Pharm; 2013 Jan; 39(1):1-19. PubMed ID: 22372916
[TBL] [Abstract][Full Text] [Related]
36. Analysis of the enhanced oral bioavailability of fenofibrate lipid formulations in fasted humans using an in vitro-in silico-in vivo approach.
Fei Y; Kostewicz ES; Sheu MT; Dressman JB
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1274-84. PubMed ID: 23500116
[TBL] [Abstract][Full Text] [Related]
37. Long chain lipid based tamoxifen NLC. Part I: preformulation studies, formulation development and physicochemical characterization.
Shete H; Patravale V
Int J Pharm; 2013 Sep; 454(1):573-83. PubMed ID: 23535345
[TBL] [Abstract][Full Text] [Related]
38. Biopharmaceutical challenges associated with drugs with low aqueous solubility--the potential impact of lipid-based formulations.
O'Driscoll CM; Griffin BT
Adv Drug Deliv Rev; 2008 Mar; 60(6):617-24. PubMed ID: 18155800
[TBL] [Abstract][Full Text] [Related]
39. Solid lipid nanoparticles for parenteral drug delivery.
Wissing SA; Kayser O; Müller RH
Adv Drug Deliv Rev; 2004 May; 56(9):1257-72. PubMed ID: 15109768
[TBL] [Abstract][Full Text] [Related]
40. High melting lipid based approach for drug delivery: solid lipid nanoparticles.
Kumar S; Randhawa JK
Mater Sci Eng C Mater Biol Appl; 2013 May; 33(4):1842-52. PubMed ID: 23498204
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
